VoxCell BioInnovation

VoxCell BioInnovation and adMare BioInnovations Partner to Advance Novel Antibody Therapies in a Human-Relevant Vascularized Tissue Platform

Collaboration applies perfusable, immune-competent 3D bioprinted cancer tissue models to preclinical evaluation of next-generation oncology biologics, supporting the FDA’s push toward more predictive, human-relevant testing and reduced reliance on animal models. 13 May 2026 -- British Columbia, Canada -- VoxCell BioInnovation Inc, a developer of bioprinted vascularized human tissue models for preclinical drug development, and...
637 Bay St #300, Victoria, BC V8T 5L2

+1 672 974 8850